Premium
Use of limited sampling strategy (LSS) of S‐warfarin (S‐W) concentrations or warfarin (W) S/R ratios as a biomarker for CYP2C9 activity
Author(s) -
Ma J.D.,
Nafziger A.N.,
Kashuba A.D.,
Rowland E.,
Gaedigk A.,
Kim J.S.,
Kim M.,
Bertino J.S.
Publication year - 2003
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1016/s0009-9236(03)90409-7
Subject(s) - warfarin , cyp2c9 , biomarker , pharmacology , medicine , chemistry , biochemistry , atrial fibrillation , cytochrome p450 , metabolism
Clinical Pharmacology & Therapeutics (2003) 73 , P15–P15; doi: